Ulesfia

Ulesfia is a brand name of benzyl alcohol topical, approved by the FDA in the following formulation(s):

ULESFIA (benzyl alcohol - lotion; topical)

• 
  Manufacturer: SHIONOGI INC
  
  Approval date: April 9, 2009
  
  Strength(s): 5% ^[RLD]

Has a generic version of Ulesfia been approved?

No. There is currently no therapeutically equivalent version of Ulesfia available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ulesfia. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Methods and compositions for topical treatment of ectoparasites
  Patent 5,858,383
  Issued: January 12, 1999
  Inventor(s): Precopio; Michael J.
  Assignee(s): Summers Laboratories, Inc.
  Methods and compositions for the topical treatment of ectoparasites on animal skin utilizing a water-soluble or water-dispersible, substantially air-impermeable liquid composition.
  
  Patent expiration dates:
  
  
  • August 11, 2017
    
    ✓ 
    Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS
  
  



• 
  Methods and compositions for topical treatment of ectoparasites
  Patent 6,139,859
  Issued: October 31, 2000
  Inventor(s): Precopio; Michael J
  Assignee(s): Summers Laboratories, Inc.
  Methods and compositions for the topical treatment of ectoparasites on animal skin utilizing a water-soluble or water-dispersible, substantially air-impermeable liquid composition.
  
  Patent expiration dates:
  
  
  • August 11, 2017
    
    ✓ 
    Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS
  
  



• 
  Ectoparasite asphyxiator compositions and methods for their applications
  Patent 6,793,931
  Issued: September 21, 2004
  Inventor(s): Michael J; Precopio
  Assignee(s): Summers Laboratories, Inc.
  Water-soluble or water-dispersible, substantially air-impermeable, pharmacologically acceptable, liquid barrier compositions for treating ectoparasite infestations on animal skin and hair, wherein the compositions contain at least one monohydric aralkyl alcohol to prevent the ectoparasites from closing their respiratory systems.
  
  Patent expiration dates:
  
  
  • July 11, 2022
    
    ✓ 
    Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS
    ✓ 
    Drug product
  
  



• 
  Ectoparasite asphyxiator compositions and methods for their application
  Patent 7,294,342
  Issued: November 13, 2007
  Inventor(s): Precopio; Michael J
  Assignee(s): Summers Laboratories, Inc.
  Water-soluble or water-dispersible, substantially air-impermeable, pharmacologically acceptable, liquid barrier compositions for treating ectoparasite infestations on animal skin and hair, wherein the compositions contain at least one monohydric aralkyl alcohol to prevent the ectoparasites from closing their respiratory systems, and wherein the compositions are free from pesticides.
  
  Patent expiration dates:
  
  
  • May 19, 2024
    
    ✓ 
    Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • April 9, 2014 - NEW CHEMICAL ENTITY
  
  

See also...

• Ulesfia Consumer Information (Drugs.com)
• Ulesfia Lotion Consumer Information (Wolters Kluwer)
• Benzyl Alcohol Consumer Information (Drugs.com)
• Benzyl Alcohol Lotion Consumer Information (Wolters Kluwer)